Citigroup’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $274K | Buy |
|
|||||
|
2024
Q3 | $400K | Buy |
|
|||||
|
2024
Q2 | $64K | Sell |
|
|||||
|
2024
Q1 | $298K | Sell |
|
|||||
|
2023
Q4 | $802K | Buy |
|
|||||
|
2023
Q3 | $565K | Buy |
|
|||||
|
2023
Q2 | $980K | Buy |
|
|||||
|
2023
Q1 | $385K | Sell |
|
|||||
|
2022
Q4 | $754K | Sell |
|
|||||
|
2022
Q3 | $1.92M | Buy |
|
|||||
|
2022
Q2 | $336K | Buy |
|
|||||
|
2022
Q1 | $243K | Sell |
|
|||||
|
2021
Q4 | $493K | Buy |
|
|||||
|
2021
Q3 | $789K | Buy |
|
|||||
|
2021
Q2 | $392K | Buy |
|
|||||
|
2021
Q1 | $271K | Sell |
|
|||||
|
2020
Q4 | $561K | Buy |
|
|||||
|
2020
Q3 | $281K | Sell |
|
|||||
|
2020
Q2 | $629K | Buy |
|
|||||
|
2020
Q1 | $313K | Buy |
|
|||||
|
2019
Q4 | $248K | Sell |
|
|||||
|
2019
Q3 | $350K | Buy |
|
|||||
|
2019
Q2 | $335K | Sell |
|
|||||
|
2019
Q1 | $423K | Buy |
|
|||||
|
2018
Q4 | $405K | Buy |
|
|||||
|
2018
Q3 | $213K | Buy |
|
|||||
|
2018
Q2 | $6K | Sell |
|
|||||
|
2018
Q1 | $11K | Sell |
|
|||||
|
2017
Q4 | $14K | Buy |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2017
Q2 | $6K | Sell |
|
|||||
|
2017
Q1 | $7K | Buy |
|
|||||
|
2016
Q4 | $6K | Hold |
|
|||||
|
2016
Q3 | $4K | Sell |
|
|||||
|
2016
Q2 | $86K | Sell |
|
|||||
|
2016
Q1 | $223K | Buy |
|
|||||
|
2015
Q4 | $364K | Buy |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $106K | Sell |
|
|||||
|
2015
Q1 | $98K | Sell |
|
|||||
|
2014
Q4 | $133K | Buy |
|
|||||
|
2014
Q3 | $6K | Buy |
|
|||||
|
2014
Q2 | $2K | Sell |
|
|||||
|
2014
Q1 | $35K | Buy |
|